摘要
Nasopharyngeal carcinoma(NPC)is a malignant epithelial carcinoma of the head and neck region which mainly distributes in southern China and Southeast Asia and has a crucial association with the Epstein–Barr virus.Based on epidemiological data,both incidence and mortality of NPC have significantly declined in recent decades grounded on the improvement of living standard and medical level in an endemic region,in particular,with the clinical use of individualized chemotherapy and intensity-modulated radiotherapy(IMRT)which profoundly contributes to the cure rate of NPC patients.To tackle the challenges including local recurrence and distant metastasis in the current NPC treatment,we discussed the implication of using targeted therapy against critical molecules in various signal pathways,and how they synergize with chemoradiotherapy in the NPC treatment.Combination treatment including targeted therapy and IMRT or concurrent chemoradiotherapy is presumably to be future options,which may reduce radiation or chemotherapy toxicities and open new avenues for the improvement of the expected functional outcome for patients with advanced NPC.
基金
supported by the National Natural Science Foundation of China(grant nos.81773179 and 81272972(C.R.),and grant no.81472355(X.J.))
the Provincial Natural Science Foundation of Hunan(grant nos.2020JJ4771,2016JJ2172(W.L.))
the National Basic Research Program of China(2010CB833605(C.R.))
the Program for New Century Excellent Talents in University(NCET-10-0790(C.R.))
the Hunan Provincial Science and Technology Department(grant nos.2016JC2049(C.R.),2014FJ6006(X.J.))
the Undergraduate Training Programs for Innovation and Entrepreneurship(UTPIE,S2020105330083(Y.K.)).
